Drug Trial Radar · NCT00000218
Pharmacotherapy and Intensive Treatment - 2
Last checked: Nov 20, 2026Latest source record: Jan 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
353
Actual
Start
Not stated
Primary completion
Not stated
Study completion Jun 2005
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- VA Office of Research and Development
- First posted
- Sep 21, 1999
Design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.
Conditions
- Cocaine-Related Disorders
- Substance-Related Disorders
Interventions
CarbamazepineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Severity addiction
- Depression
- Depression, anxiety
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Kansas
Kansas City, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.